Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Growth hormone positive effects on craniofacial complex in Turner syndrome (CROSBI ID 231311)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Juloski, Jovana ; Dumančić, Jelena ; Šćepan, Ivana ; Lauc, Tomislav ; Milašin, Jelena ; Kaić, Zvonimir ; Dumić, Miroslav ; Babić, Marko Growth hormone positive effects on craniofacial complex in Turner syndrome // Archives of oral biology, 71 (2016), 10-15. doi: 10.1016/j.archoralbio.2016.06.012

Podaci o odgovornosti

Juloski, Jovana ; Dumančić, Jelena ; Šćepan, Ivana ; Lauc, Tomislav ; Milašin, Jelena ; Kaić, Zvonimir ; Dumić, Miroslav ; Babić, Marko

engleski

Growth hormone positive effects on craniofacial complex in Turner syndrome

Turner syndrome occurs in phenotypic females with complete or partial absence of X chromosome. The leading symptom is short stature, while numerous but mild stigmata manifest in the craniofacial region. These patients are commonly treated with growth hormone to improve their final height. The aim of this study was to assess the influence of long-term growth hormone therapy on craniofacial morphology in Turner syndrome patients. In this cross-sectional study cephalometric analysis was performed on 13 lateral cephalograms of patients with 45, X karyotype and the average age of 17.3 years, who have received growth hormone for at least two years. The control group consisted of 13 Turner syndrome patients naive to growth hormone treatment, matched to study group by age and karyotype. Sixteen linear and angular measurements were obtained from standard lateral cephalograms. Standard deviation scores were calculated in order to evaluate influence of growth hormone therapy on craniofacial components. In Turner syndrome patients treated with growth hormone most of linear measurements were significantly larger compared to untreated patients. Growth hormone therapy mainly influenced posterior face height, mandibular ramus height, total mandibular length, anterior face height and maxillary length. While the increase in linear measurements was evident, angular measurements and facial height ratio did not show statistically significant difference. Acromegalic features were not found. Long-term growth hormone therapy has positive influence on craniofacial development in Turner syndrome patients, with the greatest impact on posterior facial height and mandibular ramus. However, it could not compensate X chromosome deficiency and normalize craniofacial features.

Monosomy X ; Cephalometry ; Maxillofacial development ; Human growth hormone ; X chromosome ; Mandible

This work was supported by the grant # 175075 of the Serbian Ministry of Education and Science. The research project “Charac-teristics of the craniofacial complex in gonadal dysgenesis” was supported by the Croatian Ministry of Science and Technology, grant 3-02-383.

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

71

2016.

10-15

objavljeno

0003-9969

10.1016/j.archoralbio.2016.06.012

Povezanost rada

Dentalna medicina

Poveznice
Indeksiranost